Clinical Trial Update: Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating decitabine with gemcitabine and oxaliplatin for relapsed/refractory peripheral T-cell lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Decitabine (Decitabine)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Peripheral T-cell Lymphoma (PTCL) | Phase 2 | Status: TERMINATED